Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:hedge_fund
asset management company |
| gptkbp:assetsUnderManagement |
over $10 billion
|
| gptkbp:country |
gptkb:United_States
|
| gptkbp:focusesOn |
gptkb:biotechnology
pharmaceuticals medical devices healthcare services |
| gptkbp:foundedYear |
1994
|
| gptkbp:founder |
gptkb:James_Flynn
|
| gptkbp:headquartersLocation |
gptkb:New_York_City
|
| https://www.w3.org/2000/01/rdf-schema#label |
Deerfield Management
|
| gptkbp:industry |
healthcare investment
|
| gptkbp:notableInvestment |
gptkb:Moderna
gptkb:Insmed gptkb:Intercept_Pharmaceuticals gptkb:Blueprint_Medicines |
| gptkbp:numberOfEmployees |
over 150
|
| gptkbp:regulates |
SEC settlement 2017
|
| gptkbp:website |
https://www.deerfield.com/
|
| gptkbp:bfsParent |
gptkb:Melinta_Therapeutics
gptkb:Quartet_Health |
| gptkbp:bfsLayer |
7
|